Position in SRZN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$351,804
-$334,411 QoQ
Shares Held
661,842
-1.5% QoQ
Ownership
5.63%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#40
of 70 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SRZN Over Time
Shares Held
Position Value (USD)
Derivatives in SRZN
reported options exposure · as of Sep 30, 2024CallValue
$0
CallShares
648,285
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026LMR Partners LLP holds $188,560,243 across 75 Biotechnology names. SRZN ranks #49 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
134,214 | $40,402,439 | |
| 2 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
223,995 | $21,835,032 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,306 | $13,908,683 | |
| 4 | TNGX |
Tango Therapeutics, Inc.
|
347,106 | $10,850,533 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
5,112,098 | $8,521,240 | |
| 6 | ARGX |
Argenx SE
|
8,200 | $7,607,714 | |
| 7 | DFTX |
Definium Therapeutics, Inc.
|
150,200 | $7,065,408 | |
| 8 | NKTR |
Nektar Therapeutics
|
100,000 | $6,981,000 |
All Filings in SRZN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 SRZNW | — | 648,285 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $351,804 | 13,557 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 SRZNW | — | 648,285 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $686,215 | 23,557 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 SRZNW | — | 648,285 | Shares | Sole | 2026-02-17 | |
| 2025-12-31 | $532,388 | 23,557 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 SRZNW | — | 648,285 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 SRZNW | — | 648,285 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 SRZNW | — | 648,285 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 SRZNW | — | 648,285 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 SRZNW | — | 648,285 | Call | Sole | 2024-11-07 | |
| 2024-06-30 SRZNW | — | 648,285 | Shares | Other | 2024-08-14 | |
| 2024-03-31 SRZNW | — | 648,285 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 SRZNW | — | 648,285 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 SRZNW | — | 648,285 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 SRZNW | — | 648,285 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 SRZNW | — | 648,285 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 SRZNW | — | 648,285 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 SRZNW | — | 433,821 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 SRZNW | — | 418,219 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 SRZNW | — | 404,966 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 SRZNW | — | 80,696 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 SRZNW | — | 67,680 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 CHFW | — | 172,064 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 CHFW | — | 149,856 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||